ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Educational Symposium

The Role of Hemodiafiltration in the Management of Dialysis-Dependent Chronic Kidney Failure

October 25, 2024 | 12:45 PM - 01:45 PM

Location: TBD, Marriott Marquis

Session Description

There has been increasing recognition of hemodiafiltration (HDF) for the management of patients with dialysis-dependent chronic kidney failure. HDF employs increased convection in combination with diffusion in an effort to enhance the removal of large solutes such as beta-2 microglobulin and kappa and lambda light chains. Prior randomized controlled trials comparing HDF to conventional hemodialysis showed conflicting results in terms of survival benefit and reduction in plasma levels of large solutes. Of particular interest is a recent randomized controlled trial of HDF employing higher convection volumes which demonstrated survival benefit.

This symposium reviews the technological aspects and considerations that are required to provide HDF therapy. Data from HDF trials investigating quality of life and mortality in patients with dialysis-dependent chronic kidney failure will also be discussed.

Support is provided by an educational grant from Fresenius Medical Care Renal Therapies Group LLC.

Learning Objective(s)

  • Discuss the technological considerations (e.g., replacement fluid, dialyzer membrane, machine) required to provide HDF therapy
  • Describe data from the trials investigating the effect of HDF on outcomes in patients with dialysis-dependent chronic kidney failure

Learning Pathway(s)

  • Dialysis

Moderator

Presentations